Healthcare Exclusive | As India faces shortage of remdesivir, Cipla says its supplies will hit market in next 1-2 days Updated : July 08, 2020 01:18 PM IST Cipla has contracted the manufacturing of remdesivir to Mumbai-based BDR Pharma that also makes the active pharmaceutical ingredient (API) for the drug. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.